FDA Approves Genzyme's Mozobil - Provides Stem Cell Mobilization For Autologous Transplantation In NHL And Multiple ... (Medical News Today)
Genzyme Corporation (Nasdaq: GENZ) has announced that the U.S.

FDA Approves Boston Scientific's Express(R) SD Renal Stent System (Medical News Today)
Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved the Express SD Renal Monorail Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries.

Neuralstem Files FDA Application for First ALS Stem Cell Trial (ITNews)
ROCKVILLE, Maryland, December 19 /PRNewswire/ -- Neuralstem, Inc. (NYSE Alternext US: CUR) announced this morning that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a clinical trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).